N/A (American Regent, Inc.)
Welcome to the PulseAid listing for the N/A drug offered from American Regent, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | American Regent, Inc. |
NON-PROPRIETARY NAME: | busulfan |
SUBSTANCE NAME: | BUSULFAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-04-01 |
END MARKETING DATE: | 0000-00-00 |
N/A HUMAN PRESCRIPTION DRUG Details:
Item Description | N/A from American Regent, Inc. |
LABELER NAME: | American Regent, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2017-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0517-0920_a4944e7c-0a07-4788-943a-6972a960a5d3 |
PRODUCT NDC: | 0517-0920 |
APPLICATION NUMBER: | ANDA202259 |
Other BUSULFAN Pharmaceutical Manufacturers / Labelers: